[The relationship between inflammation, cognitive disorders and neuroimaging data in schizophrenia].

Autor:	Ushakov VL; National Researh Center «Kurchatov Institute», Moscow, Russia.; Alekseev Mental-health Hospital No1, Moscow, Russia., Malashenkova IK; National Researh Center «Kurchatov Institute», Moscow, Russia.; Federal Research and Clinical Center of physical-chemical medicine, Moscow, Russia., Kostyuk GP; Alekseev Mental-health Hospital No1, Moscow, Russia., Zakharova NV; Alekseev Mental-health Hospital No1, Moscow, Russia., Krynskiy SA; National Researh Center «Kurchatov Institute», Moscow, Russia., Kartashov SI; National Researh Center «Kurchatov Institute», Moscow, Russia., Ogurtsov DP; National Researh Center «Kurchatov Institute», Moscow, Russia.; Federal Research and Clinical Center of physical-chemical medicine, Moscow, Russia., Bravve LV; Alekseev Mental-health Hospital No1, Moscow, Russia., Kaydan MA; Alekseev Mental-health Hospital No1, Moscow, Russia., Hailov NA; National Researh Center «Kurchatov Institute», Moscow, Russia., Chekulaeva EI; National Researh Center «Kurchatov Institute», Moscow, Russia., Didkovsky NA; Federal Research and Clinical Center of physical-chemical medicine, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2020; Vol. 120 (11), pp. 70-78.
DOI:	10.17116/jnevro202012011170
Abstrakt:	Objective: To search for the relationship between the results of functional imaging, immunological parameters and laboratory markers of inflammation in schizophrenia, taking into account cognitive impairment in patients, and to consider the possibility of using a multidisciplinary approach to diagnosis, treatment and prognosis of schizophrenia. Material and Methods: The study included 25 patients with schizophrenia and 13 healthy volunteers. Psychiatric scales were administered to evaluate the patient's condition. The main indicators of humoral immunity, the level of markers of inflammation, key pro-inflammatory and anti-inflammatory cytokines, and growth factor VEGF were determined by ELISA. Brain MRI was performed. All calculated tractographic data are included in the connection database to study the effect of immunological markers and the degree of severity of cognitive impairment. Results and Conclusion: Levels of markers of systemic inflammation and growth factor VEGF-A as well as the activation of humoral immunity are increased in patients with schizophrenia compared with controls. For the first time, the relationship of immunological parameters with the coefficient of quantitative anisotropy in the area of the corpus callosum in schizophrenia was revealed. The results indicate the possible value of indicators of the activation of the humoral immune response and systemic inflammation as markers of neurophysiological changes and cognitive dysfunction in schizophrenia.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu